01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
On Thursday, January 30, members from Verrill's Employment & Labor group, as well as some from the E...
Read More >
U.S. Citizenship and Immigration Services (USCIS) opened its initial registration period for the fis...
Read More >
The IRS recently released a final regulation clarifying how voluntary employees’ beneficiary associ...
Read More >
Car accidents are already a harrowing and dangerous experience for the people involved, but it can b...
Read More >
On June 5, 2019, the Massachusetts Supreme Judicial Court (SJC) issued a decision emphasizing that a...
Read More >
On August 6, 2019, in State of Texas v. Equal Employment Opportunity Commission, the U.S. Court of A...
Read More >